John Lai

Chief Executive Officer of PetVivo Holdings Inc.

[PetVivo Holdings, Inc. @PetVivo]

PetVivo’s platform story extends beyond today’s commercial products.

In 2025, PetVivo entered into a Master Services Agreement with PiezoBioMembrane, Inc., a UConn TIP startup, to collaborate on next‑generation implantable biomaterials that combine PiezoBio’s biodegradable piezoelectric nanofibers with PetVivo’s ECM‑based materials.

The goal of this work is to explore functional, biologically activated piezo‑biomaterials designed to stimulate tissue and bone regeneration without wires or batteries, an example of the kind of research and development that underpins PetVivo’s long‑term innovation strategy.

Read UConn’s profile on the collaboration, https://t.co/SsQEHdachD

[John Lai @therealjohnlai]

I got my Wall Street south look. Miami!

[John Lai @therealjohnlai]

Getting ready for my AI tokenization presentation. Here with one of our attorneys from New York.

[AgenticPet @AgenticPet]

Tomorrow will be a big day for us and @PetVivo! We'll try to keep you all in the loop.

This is as bullish as it can get, ladies and gents! 👀

[Water Tower Research LLC @WTR_Research]

In this episode of WTR Small-Cap Spotlight, PetVivo Holdings Inc (NASDAQ: $PETV) CEO John Lai joins WTR’s Tim Gerdeman and Robert Sassoon to discuss the company’s regenerative medicine platform for companion animals.

• The discussion highlights PetVivo’s product portfolio led by Spryng, its cartilage-mimicking protein particle matrix, alongside the company’s off-the-shelf Precise PRP product
• Lai also discusses the BioPiezo collaboration with the University of Connecticut, pairing Spryng with nanofiber technology aimed at driving cartilage regeneration with potential future human applications
• The conversation explores the upcoming launch of https://t.co/g5zigrZIcu, an agentic AI platform for veterinary practices, and the company’s pathway toward cash-flow breakeven

Listen now on all platforms or on the WTR website.

Podcast Platforms: https://t.co/dhzakkNnHX
Website: https://t.co/md4RhPZ6ND

$PETV #VeterinaryMedicine #RegenerativeMedicine #AI #Healthcare #Biotech #CompanionAnimals #NASDAQ #Investing #WaterTowerResearch

[PetVivo Holdings, Inc. @PetVivo]

PetVivo Holdings Inc CEO, John Lai, guest-starred on the Water Tower Research LLC podcast for a great discussion with the host.

Watch the full interview now!

https://t.co/d1eRQGc0v9

[AgenticPet @AgenticPet]

🚀 Miami is about to become a hotspot for the future of AI, automation & Web3.

Industry leaders from BAM Analytix, PetVivo Holdings, MBody AI, Digitallandia Holdings and more are coming together on May 27 for an evening packed with innovation, networking and next-gen tech discussions. 🔥

The future isn’t coming. It’s already being built.

[Water Tower Research LLC @WTR_Research]

Check out Robert Sassoon's recap from his recent podcast with John Lai, CEO and President of PetVivo Holdings Inc, Inc. (OTCQB: $PETV).

Those interested can listen to this podcast on all platforms or on our website. Links are accessible in our full report!

https://t.co/35eeInlxpo

$PETV #PetVivo #VeterinaryMedicine #RegenerativeMedicine #AnimalHealth #VetTech #ArtificialIntelligence #HealthcareInnovation #Biotech #CompanionAnimals #MedicalDevices #DigitalHealth #AIHealthcare #LifeSciences #SmallCapStocks #InvestorInsights #WaterTowerResearch @PetVivo

[John Lai @therealjohnlai]

Podcast with Water Tower Research on PetVivo.

https://t.co/K3dSLI4idw

[John Lai @therealjohnlai]

The stock conference is about to begin. I got the girls dancing. 💃🏻 🕺🏻

[John Lai @therealjohnlai]

Good afternoon dinner cigar. The good old Wall Street days at Delmonico’s.

[PetVivo Holdings, Inc. @PetVivo]

What is PetVivo Holdings?

PetVivo Holdings, Inc., $PETV, is an emerging biomedical device company that manufactures, commercializes, and licenses innovative medical devices and therapeutics for companion animals.

Our lead product, Spryng with OsteoCushion Technology, is a veterinarian‑administered intra‑articular injection designed to help manage lameness, joint pain, and osteoarthritis in dogs, cats, and horses.

PetVivo also offers PrecisePRP, an off‑the‑shelf platelet‑rich plasma product for veterinary use, and is developing an AI‑driven platform, https://t.co/qbB5KVXd5L, to support veterinary practices.

Our strategy is to adapt human biotech and medical device technologies for the animal‑health market and to build value through a protected portfolio of patented biomaterials, products, and processes.

Follow along to learn more or visit our website at https://t.co/NNC7LlvWTk

[AgenticPet @AgenticPet]

🐎🐾 National Help a Horse Day

A day to recognize the care, respect, and support these incredible animals deserve. ❤️

For @PetVivo, advancing animal health and improving quality of life isn’t just a goal, it’s a commitment, especially for animals like horses that give so much.

@AgenticPet proudly stands with and fully supports this commitment too.. 😇
#HelpAHorseDay

[AgenticPet @AgenticPet]

💡🐾 World Creativity & Innovation Day

Innovation isn’t just about tech, it’s about creating better lives for our pets. ❤️

From smarter care solutions to AI-powered tools and healthier treatments, the future of pet care is being built right now.

Because our pets deserve the absolute best!🐶🐱
#InnovationDay

[PetVivo Holdings, Inc. @PetVivo]

PetVivo Holdings, Inc. to Present at the Market Movers Investor Summit https://t.co/cmYeOfPicZ

[John Lai @therealjohnlai]

Conference food IVAPM

[John Lai @therealjohnlai]

Our booth at IVAPM

[John Lai @therealjohnlai]

IVAPM conference

[John Lai @therealjohnlai]

Morning session at the IVAPM

[John Lai @therealjohnlai]

https://t.co/pdsdu1Eqip